BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information about Prismaflex Continuous Renal Replacement System from Gambro

Product group Injections / Infusions / Transfusions / Dialysis
Reference 03845/06

The company Gambro Lundia AB has issued an Advisory Notice to costumers of the Prismaflex Continuous Renal Replacement System. Users are notified on a correct procedure to remove flow rate discrepancies. A new software version rectifies all known causes of such a behaviour.

Information about Prismaflex Continuous Renal Replacement System from Gambro , Download_VeroeffentlichtAm_EN PDF, 91KB, File does not meet accessibility standards